Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.880
-0.030 (-1.03%)
At close: Nov 4, 2024, 4:00 PM
2.850
-0.030 (-1.04%)
Pre-market: Nov 5, 2024, 8:00 AM EST
Editas Medicine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 61.76 | 78.12 | 19.71 | 25.54 | 90.73 | 20.53 | Upgrade
|
| Revenue Growth (YoY) | 150.95% | 296.32% | -22.83% | -71.85% | 341.93% | -35.71% | Upgrade
|
| Cost of Revenue | 132.53 | 177.65 | 174.96 | 142.51 | 158 | 96.9 | Upgrade
|
| Gross Profit | -70.77 | -99.53 | -155.25 | -116.96 | -67.26 | -76.37 | Upgrade
|
| Selling, General & Admin | 70.09 | 69.65 | 70.7 | 76.18 | 67.58 | 64.56 | Upgrade
|
| Operating Expenses | 157.75 | 69.65 | 70.7 | 76.18 | 67.58 | 64.56 | Upgrade
|
| Operating Income | -228.52 | -169.18 | -225.95 | -193.15 | -134.84 | -140.92 | Upgrade
|
| Interest & Investment Income | 17.96 | 17.57 | 5.52 | 0.61 | 2.61 | 7.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.59 | - | - | 0.04 | -0.11 | -0.14 | Upgrade
|
| EBT Excluding Unusual Items | -208.97 | -151.62 | -220.43 | -192.5 | -132.34 | -133.75 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.6 | -1.6 | - | - | 16.37 | - | Upgrade
|
| Pretax Income | -210.57 | -153.22 | -220.43 | -192.5 | -115.98 | -133.75 | Upgrade
|
| Net Income | -210.57 | -153.22 | -220.43 | -192.5 | -115.98 | -133.75 | Upgrade
|
| Net Income to Common | -210.57 | -153.22 | -220.43 | -192.5 | -115.98 | -133.75 | Upgrade
|
| Shares Outstanding (Basic) | 82 | 76 | 69 | 68 | 59 | 50 | Upgrade
|
| Shares Outstanding (Diluted) | 82 | 76 | 69 | 68 | 59 | 50 | Upgrade
|
| Shares Change (YoY) | 13.03% | 10.63% | 1.55% | 15.37% | 17.26% | 6.13% | Upgrade
|
| EPS (Basic) | -2.56 | -2.02 | -3.21 | -2.85 | -1.98 | -2.68 | Upgrade
|
| EPS (Diluted) | -2.56 | -2.02 | -3.21 | -2.85 | -1.98 | -2.68 | Upgrade
|
| Free Cash Flow | -191.36 | -136.9 | -181.47 | -171.78 | -187.01 | -46.84 | Upgrade
|
| Free Cash Flow Per Share | -2.33 | -1.80 | -2.64 | -2.54 | -3.19 | -0.94 | Upgrade
|
| Gross Margin | -114.59% | -127.40% | - | - | -74.13% | - | Upgrade
|
| Operating Margin | -370.02% | -216.56% | -1146.26% | -756.13% | -148.61% | -686.39% | Upgrade
|
| Profit Margin | -340.96% | -196.13% | -1118.26% | -753.61% | -127.82% | -651.43% | Upgrade
|
| Free Cash Flow Margin | -309.84% | -175.23% | -920.59% | -672.49% | -206.11% | -228.12% | Upgrade
|
| EBITDA | -222.63 | -163.12 | -219.61 | -188.09 | -130.88 | -138.09 | Upgrade
|
| EBITDA Margin | - | -208.80% | - | - | -144.25% | - | Upgrade
|
| D&A For EBITDA | 5.89 | 6.06 | 6.34 | 5.05 | 3.96 | 2.83 | Upgrade
|
| EBIT | -228.52 | -169.18 | -225.95 | -193.15 | -134.84 | -140.92 | Upgrade
|
| EBIT Margin | - | -216.56% | - | - | -148.61% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.